Financial Comparison: Gadsden Properties (OTCMKTS:GADS) vs. BioSig Technologies (NASDAQ:BSGM)

BioSig Technologies (NASDAQ:BSGMGet Free Report) and Gadsden Properties (OTCMKTS:GADSGet Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Profitability

This table compares BioSig Technologies and Gadsden Properties’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BioSig Technologies -44,832.50% N/A -776.49%
Gadsden Properties N/A N/A N/A

Analyst Ratings

This is a summary of current recommendations and price targets for BioSig Technologies and Gadsden Properties, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioSig Technologies 0 0 1 0 3.00
Gadsden Properties 0 0 0 0 0.00

BioSig Technologies presently has a consensus price target of $2.75, suggesting a potential upside of 170.94%. Given BioSig Technologies’ stronger consensus rating and higher probable upside, research analysts clearly believe BioSig Technologies is more favorable than Gadsden Properties.

Insider & Institutional Ownership

7.2% of BioSig Technologies shares are held by institutional investors. 17.0% of BioSig Technologies shares are held by company insiders. Comparatively, 5.0% of Gadsden Properties shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

BioSig Technologies has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, Gadsden Properties has a beta of -5.38, indicating that its share price is 638% less volatile than the S&P 500.

Valuation & Earnings

This table compares BioSig Technologies and Gadsden Properties”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
BioSig Technologies $20,000.00 874.93 -$29.04 million N/A N/A
Gadsden Properties N/A N/A N/A N/A N/A

Gadsden Properties has lower revenue, but higher earnings than BioSig Technologies.

Summary

BioSig Technologies beats Gadsden Properties on 7 of the 9 factors compared between the two stocks.

About BioSig Technologies

(Get Free Report)

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

About Gadsden Properties

(Get Free Report)

Gadsden Properties, Inc. is a Nevada corporation that was formed on December 28, 2010. Gadsden concentrates primarily on investments in high quality income-producing assets, residential developments and other opportunistic commercial properties in secondary and tertiary markets across the United States. The Company derives value from smaller, flexible retail investments that range from $5 million to $50 million and off-market mixed-use properties ranging from $50 million to $250 million. As a result of this chosen strategy, we believe that Gadsden is developing a unique competitive advantage that generally allows the Company to invest in markets and assets that are often overlooked by larger institutional investors, such as publicly-traded REITs and other large institutional investors. As part of its strategy, Gadsden attracts specific sellers that prefer the tax deferral advantages offered through issuing operating partnership units in exchange for their properties. These real estate assets are typically operated by independent owners that are seeking to monetize their real estate holdings, and who are typically not well capitalized or well-seasoned real estate operators. These transactions create a variety of outcomes for Gadsden and the sellers typically resulting in lease-up and value-added opportunities that may not be otherwise achieved.

Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.